Ventripoint Diagnostics Ltd. (TSXV:VPT)

Canada flag Canada · Delayed Price · Currency is CAD
0.1200
-0.0050 (-4.00%)
At close: Feb 9, 2026
Market Cap21.82M +34.5%
Revenue (ttm)175.62K +28.6%
Net Income-4.06M
EPS-0.02
Shares Out181.87M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume66,313
Average Volume110,866
Open0.1250
Previous Close0.1250
Day's Range0.1200 - 0.1250
52-Week Range0.0750 - 0.2000
Beta0.17
RSI48.01
Earnings DateApr 30, 2026

About Ventripoint Diagnostics

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. It also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, in... [Read more]

Sector Healthcare
CEO Hugh MacNaught
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol VPT
Full Company Profile

Financial Performance

In 2024, Ventripoint Diagnostics's revenue was 95,172, an increase of 93.51% compared to the previous year's 49,183. Losses were -4.92 million, 0.98% more than in 2023.

Financial Statements

News

Ventripoint Issues Shares for Debt Settlement and Awards Option Grants

Toronto, Ontario – TheNewswire - January 28, 2026 – Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Corporation ", TSXV:VPT) is pleased to announce that it received approval from the TSX Ventur...

12 days ago - TheNewswire

AI Medical Imaging Revolution: Software-Native Tech Disrupts $45B Market

ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. VANCOUVER, BC , Jan. 27, 2026 /PRNewswire/ -- USANewsGroup .com News Commentary – The global medical imaging market hit a massive $45.5 billion in 2026...

13 days ago - Benzinga

Ventripoint Announces Closing of Non-Brokered Units Private Placement

Toronto, Ontario – TheNewswire - January 19, 2026 – Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”) , ( TSXV:VPT) announces the closing of its previously announced non-brokered ...

21 days ago - TheNewswire

Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic

ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. USANewsGroup.com News Commentary VANCOUVER, BC , Jan. 16, 2026 /PRNewswire/ -- The medical imaging world is hitting a massive reset button as AI-driven...

24 days ago - Benzinga

Ventripoint Issues Shares for Payment of Debenture Interest

Toronto, Ontario – TheNewswire - January 16, 2026 – Ventripoint Diagnostics Ltd.(TSXV:VPT; OTC:VPTDF) (“Ventripoint” or the “Corporation”) a leader in AI-enhanced cardiac imaging solutions announces ...

24 days ago - TheNewswire

Ventripoint Doubles the Size of Private Placement Due to Strong Investor Demand

Toronto, Ontario – TheNewswire - January 7, 2026 -- Ventripoint Diagnostics Ltd. (Ventripoint or the Corporation, TSXV:VPT), a leading innovator in AI-powered cardiac imaging technology, today announc...

4 weeks ago - TheNewswire

Ventripoint Announces Non-Brokered Units Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES     Toronto, Ontario, December 30, 2025 – TheNewswire - Ventripoint Diagnostics Ltd. (“ Ventripoint ” ...

5 weeks ago - TheNewswire

Ventripoint Diagnostics Announces Collaboration with Summit Sciences

Engagement to develop economic and ROI models Toronto, Ontario – TheNewswire - December 18, 2025 - Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company "), (TSXV:VPT; OTC:VPTDF) a leader in ...

7 weeks ago - TheNewswire

Ventripoint to Issue Shares for Payment of Debenture Interest

Toronto, Ontario – TheNewswire - December 17, 2025 – Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”, TSXV:VPT) announces it will satisfy debenture interest payment obligations wi...

7 weeks ago - TheNewswire

Ventripoint Unveils a Global Model for A.I.-Enhanced Heart Care through Partnership with the Nisga'a Valley Health Authority

New care delivery model to provide advanced cardiac imaging to remote and Indigenous communities in British Columbia, across Canada, and worldwide. Toronto, Ontario – TheNewswire - December 12, 2025 -...

2 months ago - TheNewswire

Ventripoint Diagnostics Announces Appointment of David Swetlow as Chief Financial Officer

New CFO appointment strengthens Ventripoint's leadership team and supports global rollout of AI-powered VMS+™ cardiac imaging platform. Toronto, Ontario – TheNewswire - December 3, 2025 - Ventripoint ...

2 months ago - TheNewswire

CEO.CA's Inside the Boardroom: Ventripoint Diagnostics: We Made Ultrasound as Good as MRI - Now Here's How We Scale It

Toronto, Ontario--(Newsfile Corp. - November 27, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior mini...

2 months ago - Newsfile Corp

Ventripoint Announces Debt Settlement Agreements

Toronto, Ontario – TheNewswire - November 6, 2025 – Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Corporation ") , ( TSXV:VPT) is pleased to announce that it has agreed to settle an aggregat...

3 months ago - TheNewswire

Ventripoint Diagnostics Ltd. (VPT:CA) Shareholder/Analyst Call Transcript

Ventripoint Diagnostics Ltd. ( VPT:CA) Shareholder/Analyst Call October 30, 2025 1:00 PM EDT Company Participants Hugh MacNaught - CEO, President & Director Presentation Hugh MacNaught CEO, President...

3 months ago - Seeking Alpha

Ventripoint Diagnostics and Providence Health Care Ventures Announce Collaboration to Validate AI-Enabled Cardiac Imaging at St. Paul's Hospital

Study to evaluate potential to reduce cardiac MRI demand and expand access to advanced heart diagnostics across care settings Toronto, Ontario – TheNewswire - October 29, 202 5 - Ventripoint Diagnosti...

3 months ago - TheNewswire

Ventripoint Provides Corporate Update and Announces Shareholder Teleconference

Toronto, Canada — TheNewswire --- October 24, 2025 — Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF), a leading provider of innovative cardiac diagnostic solutions...

3 months ago - TheNewswire

Ventripoint Announces Closing of Second and Final Tranche of Non-Brokered Convertible Debenture Units Private Placement

Toronto, Ontario, October 14, 2025 – TheNewswire - Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”, TSXV:VPT) announces the issuance of an additional $297,000 of unsecured convert...

4 months ago - TheNewswire

Ventripoint Announces Extension and Up Size of Non-Brokered Convertible Debenture Unit Private Placement

Toronto, Ontario, October 3, 2025 – TheNewswire - Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”, TSXV:VPT) announces that it will seek approval of TSX Venture Exchange (“ TSXV ”...

4 months ago - TheNewswire

Ventripoint Announces Successful Completion of Key Quality Audits

Toronto, Ontario – TheNewswire - (September 19, 2024) - Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company "), (TSXV:VPT; OTC:VPTDF) is pleased to announce the successful completion of its...

5 months ago - TheNewswire

Ventripoint Announces Closing of First Tranche of Non-Brokered Convertible Debenture Unit Private Placement

Toronto, Ontario, September 3, 2025 – TheNewswire - Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”, TSXV:VPT) announces the closing of its previously announced (see press release...

5 months ago - TheNewswire

Ventripoint Announces Non-Brokered Convertible Debenture Units Private Placement and Share Issuance

Toronto, Ontario – TheNewswire - August 26, 2025 – Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”) , ( TSXV:VPT) announces a non-brokered private placement of up to CDN$500,000 ...

5 months ago - TheNewswire

Ventripoint Diagnostics Appoints Thomas Brown as Director of Congenital Heart Defect Program

Toronto, Ontario – TheNewswire - August 18, 2025 – Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”,) ( TSXV:VPT; OTC:VPTDF) a leader in AI-powered heart analysis solutions, is pl...

6 months ago - TheNewswire

Ventripoint Diagnostics Launches Targeted Congenital Heart Defect Marketing Program, Setting Stage for Multi-Segment Growth

Toronto, Ontario – TheNewswire - August 15, 2025 – Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”) , ( TSXV:VPT; OTC:VPTDF) a leader in AI-powered heart analysis solutions, toda...

6 months ago - TheNewswire

CEO.CA's Inside the Boardroom: Cardiac MRI Alternative Gets FDA Nod - Ventripoint CEO on U.S. and China Sales Plans

Toronto, Ontario--(Newsfile Corp. - August 13, 2025) -   CEO.CA ("CEO.CA"), the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior mini...

6 months ago - Newsfile Corp